GH Guardant Health, Inc.
GH Guardant Health, Inc.
Healthcare · Diagnostics & Research
Market read
Scan convergence 2 scans as of 2026-08-17 2 bull converging
POC $61.10 · VWAP $103.20 · +56.7% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
GH Price Structure
Loading timeframes…
Peers
Every watchlist GH belongs to, members best 30-day change first — GH highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare
Decision history
1 scored call · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Against street estimates
How GH's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
GH research tape
31 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.